| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1537 | 2021 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1150 | 2022 |
| Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ... The Lancet 396 (10266), 1895-1904, 2020 | 569 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 441* | 2021 |
| Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial DJ Hausenloy, RK Kharbanda, UK Møller, M Ramlall, J Aarøe, R Butler, ... The Lancet 394 (10207), 1415-1424, 2019 | 303 | 2019 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 303 | 2019 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 232 | 2022 |
| Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium DA Gorog, RF Storey, PA Gurbel, US Tantry, JS Berger, MY Chan, ... Nature Reviews Cardiology 19 (7), 475-495, 2022 | 224 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
| The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease HK Kim, US Tantry, SC Smith Jr, MH Jeong, SJ Park, MH Kim, DS Lim, ... Thrombosis and haemostasis 121 (04), 422-432, 2021 | 174 | 2021 |
| Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury … M Tanno, R Bassi, DA Gorog, AT Saurin, J Jiang, RJ Heads, JL Martin, ... Circulation research 93 (3), 254-261, 2003 | 170 | 2003 |
| Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double … JP Piccini, V Caso, SJ Connolly, KAA Fox, J Oldgren, WS Jones, ... The lancet 399 (10333), 1383-1390, 2022 | 167 | 2022 |
| Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease DA Gorog Journal of the American College of Cardiology 55 (24), 2701-2709, 2010 | 157 | 2010 |
| Antiplatelet drug'resistance'. Part 1: mechanisms and clinical measurements JM Sweeny, DA Gorog, V Fuster Nature Reviews Cardiology 6 (4), 273-282, 2009 | 148 | 2009 |
| Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on thrombosis and the … E Cenko, L Badimon, R Bugiardini, MJ Claeys, G De Luca, C de Wit, ... Cardiovascular research 117 (14), 2705-2729, 2021 | 140 | 2021 |
| Endogenous fibrinolysis: an important mediator of thrombus formation and cardiovascular risk ON Okafor, DA Gorog Journal of the American College of Cardiology 65 (16), 1683-1699, 2015 | 115 | 2015 |
| Platelet function tests in clinical cardiology: unfulfilled expectations DA Gorog, V Fuster Journal of the American College of Cardiology 61 (21), 2115-2129, 2013 | 115 | 2013 |
| Allopurinol as a therapeutic option in cardiovascular disease ON Okafor, K Farrington, DA Gorog Pharmacology & therapeutics 172, 139-150, 2017 | 106 | 2017 |
| Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis EP Navarese, AJ Lansky, DJ Kereiakes, J Kubica, PA Gurbel, DA Gorog, ... European heart journal 42 (45), 4638-4651, 2021 | 103 | 2021 |
| Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the … J Ten Berg, D Sibbing, B Rocca, E Van Belle, B Chevalier, JP Collet, ... European heart journal 42 (23), 2265-2269, 2021 | 103 | 2021 |
